Pediatric cancer recurrence presents a complex challenge for both healthcare providers and families dealing with the aftermath of childhood cancers, especially brain tumors such as gliomas.Recent advancements in technology highlight the role of AI in pediatric cancer, significantly enhancing the prediction of relapse risks.